Welcome to our dedicated page for Cohen & Steers SEC filings (Ticker: CNS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cohen & Steers, Inc. (NYSE: CNS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Cohen & Steers is a global investment manager specializing in real assets and alternative income, including listed and private real estate, preferred securities, infrastructure, resource equities, commodities and multi-strategy solutions. Its common stock is registered under Section 12(b) of the Exchange Act and trades on the New York Stock Exchange under the symbol CNS, as noted in its Form 8-K filings.
Through this page, users can review current and historical filings such as Form 8-K reports that describe material events. Recent 8-Ks include disclosures about quarterly financial results, changes in senior management positions and compensation arrangements, and the entry into a First Amendment to a senior unsecured revolving credit facility used for working capital and other general corporate purposes. These filings often reference attached exhibits, including press releases and credit agreements, which provide additional detail on the company’s operations and financing.
For investors following Cohen & Steers’ role as an investment manager, the filings page complements the firm’s fund-level communications by showing how it reports corporate-level events, governance changes and financing arrangements. While fund distribution notices and performance metrics are typically released via press releases, the SEC filings document how those and other developments are communicated under securities law.
Stock Titan enhances access to these documents with tools designed to help users navigate and interpret complex filings. Investors can use this page to locate the latest 8-Ks and other reports for Cohen & Steers, track how the company describes its financial condition and corporate actions over time, and connect these disclosures with the firm’s broader focus on real assets and alternative income.
Cohen & Steers, Inc. (CNS)
Following this transaction, the executive directly beneficially owns 10,314 CNS shares. No derivative securities transactions were reported.
Cohen & Steers, Inc. (CNS)11/20/2025, the officer acquired 187 shares of common stock at a price of $0. These shares represent dividend equivalent restricted stock units credited in connection with the company’s fourth quarter 2025 dividend on previously granted unvested restricted stock units from May 2023, January 2024, January 2025 and October 2025. After this transaction, the officer beneficially owns 26,205 shares of Cohen & Steers common stock directly.
Cohen & Steers, Inc. (CNS)11/19/2025, trusts associated with him bought additional CNS common stock in open-market purchases.
The Robert H. Steers 2018 Revocable Trust acquired 19,000 shares at a weighted average price of $59.88, bringing its reported beneficial ownership to 7,147,497 shares. The Hilltop GST Non-Exempt Descendants' Trust acquired 6,000 shares at a weighted average price of $59.86, for a reported 3,897,184 shares held after the transaction.
Additional indirect holdings include 805,920 shares held by The Sunnyridge GST Exempt Family Trust and 334 shares held by the Hamilton-Steers 2017 Trust FB Robert H. Steers, plus 139,747 shares reported as directly owned. The filing notes that Mr. Steers disclaims beneficial ownership of certain trust-held shares except to the extent of his pecuniary interest.
Cohen & Steers, Inc. insider equity update: A company officer, serving as Chief Accounting Officer and Senior Vice President, reported an automatic acquisition of 46 shares of Cohen & Steers common stock on 11/20/2025. These shares were received at a price of $0 as dividend equivalent restricted stock units tied to the issuer's fourth quarter 2025 dividend.
These dividend equivalents accrued on unvested restricted stock units originally granted in January 2022, January 2023, January 2024, and January 2025. Following this transaction, the reporting person beneficially owns 21,321 shares of Cohen & Steers common stock in direct ownership form.
Cohen & Steers, Inc. (CNS) reported an insider equity award for its President and Chief Investment Officer on a Form 4. On 11/20/2025, the executive acquired 769 shares of common stock at a price of $0, increasing his directly held position to 144,543 shares.
The filing explains that these 769 shares represent dividend equivalent restricted stock units tied to the company’s fourth quarter 2025 dividend. They accrued on previously granted unvested restricted stock units from awards made in January 2022, January 2023, January 2024, and January 2025, reflecting routine compensation-linked accruals rather than an open-market purchase.
Cohen & Steers, Inc. (CNS) reported a routine insider equity award for one of its officers, who serves as GC, Secretary and EVP. On 11/20/2025, the officer acquired 223 shares of common stock at a price of $0 per share.
The filing explains that these shares represent dividend equivalent restricted stock units tied to the company’s fourth quarter 2025 dividend, accruing on unvested restricted stock units originally granted in January 2022, January 2023, January 2024 and January 2025. Following this transaction, the officer directly holds 68,390 shares of Cohen & Steers common stock.
Cohen & Steers, Inc. insider activity: A Form 4 reports transactions by a director and 10% owner of CNS, Martin Cohen. On 11/18/2025, 100,000 shares of common stock were disposed of at a price of $0 through a transaction coded "G", reflecting a gift from the Martin Cohen 2018 Revocable Trust, which then held 8,071,461 shares indirectly.
On the same day, the reporting person bought 50,000 shares at a weighted average price of $59.69. Additional open-market purchases followed: 22,633 shares on 11/19/2025 at $59.5, 14,659 shares on 11/19/2025 at $59.91, and 12,708 shares on 11/20/2025 at $60.83. After these purchases, the reporting person directly owned 949,205 common shares.
Cohen & Steers, Inc. (CNS)22,903 shares of common stock, held directly.
The reported amount includes 22,391 restricted stock units that were previously granted by the company to the reporting person. No derivative securities such as options or warrants are listed as beneficially owned in the tables provided.
Cohen & Steers, Inc. (CNS) — Form 4 insider activity: Executive Chairman, Director, and 10% owner Robert H. Steers reported a series of open‑market purchases (code P) of CNS common stock on 11/03/2025, 11/04/2025, and 11/05/2025 at weighted average prices listed in the filing.
Through the Robert H. Steers 2018 Revocable Trust, purchases included 19,856 shares at $68.15, 1,294 at $68.66, 27,292 at $67.95, 642 at $68.39, and 19,329 at $67.61, with beneficial ownership shown as 7,128,497 shares following the last reported transaction. The Hilltop GST Non‑Exempt Descendants' Trust reported 17,200 shares at $68.21, 300 at $68.65, and 14,975 at $67.96, with 3,891,184 shares owned following the last entry.
Additional reported holdings include 805,920 shares by The Sunnyridge GST Exempt Family Trust, 334 shares by the Hamilton‑Steers 2017 Trust FB Robert H. Steers, and 139,747 shares held directly. Footnotes state Mr. Steers disclaims beneficial ownership of certain trust‑held shares except to the extent of his pecuniary interest.
FAQ
What is the current stock price of Cohen & Steers (CNS)?
What is the market cap of Cohen & Steers (CNS)?
